Skip to main content

Peer Review reports

From: Outcomes of pregnant women exposed to Sotrovimab for the treatment of COVID-19 in the BA.1 Omicron predominant era (PRESTO)

Original Submission
9 Dec 2022 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
23 Jan 2023 Reviewed Reviewer Report - Christina Megli
15 Feb 2023 Reviewed Reviewer Report
22 Feb 2023 Author responded Author comments - Jessica J. Tuan
Resubmission - Version 3
22 Feb 2023 Submitted Manuscript version 3
2 Mar 2023 Reviewed Reviewer Report
23 Mar 2023 Reviewed Reviewer Report - Christina Megli
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
25 Mar 2023 Editorially accepted
26 Apr 2023 Article published 10.1186/s12879-023-08198-9

You can find further information about peer review here.

Back to article page